LDH and LV218 are promising biomarkers for differentiating microbiologically positive and negative pleural effusions in tuberculous pleuritis. These biomarkers, particularly when combined, could improve diagnostic accuracy and clinical management.
Ma et al. (Thu,) studied this question.